| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | GDC-0941 | GDSC1000 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | -0.001 | 1 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | -0.001 | 1 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | 0.00095 | 1 |